Your browser doesn't support javascript.
loading
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
Huang, Alice; Cicin-Sain, Caroline; Pasin, Chloe; Epp, Selina; Audigé, Annette; Müller, Nicolas J; Nilsson, Jakob; Bankova, Andriyana; Wolfensberger, Nathan; Vilinovszki, Oliver; Nair, Gayathri; Hockl, Philipp; Schanz, Urs; Kouyos, Roger D; Hasse, Barbara; Zinkernagel, Annelies S; Trkola, Alexandra; Manz, Markus G; Abela, Irene A; Müller, Antonia M S.
Afiliação
  • Huang A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Cicin-Sain C; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Pasin C; Institute of Medical Virology, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Epp S; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Audigé A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Müller NJ; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Nilsson J; Department of Immunology, University Hospital Zurich, Zurich, Switzerland.
  • Bankova A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Wolfensberger N; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Vilinovszki O; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Nair G; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Hockl P; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Schanz U; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Kouyos RD; Institute of Medical Virology, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Hasse B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Zinkernagel AS; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Trkola A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Abela IA; Institute of Medical Virology, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Müller AMS; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. Electronic address: antoniamaria.mueller@usz.ch.
Transplant Cell Ther ; 28(4): 214.e1-214.e11, 2022 04.
Article em En | MEDLINE | ID: mdl-35092892
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça País de publicação: Estados Unidos